Research Article

Quantitative Analysis of Favipiravir by HPLC: Development and Validation

Table 5

Favipiravir sensitivity showing LOD and LOQ.

Conc (%)Conc. (ppm)Injection area repetition 1Injection area repetition 2Injection area repetition 3Average area

5.00.02500.0180.0190.0180.018
12.50.06250.0460.0450.0470.046
25.00.12500.0930.0940.0920.093
50.00.25000.1850.1860.1870.186
100.00.50000.3740.3730.3730.373
150.00.75000.5620.5580.560.560
200.01.00000.7460.7470.7470.747
STEYX0.0010.0010.0010.001
Slope0.74800.74640.74740.747
LOQ (ppm)0.01560.01510.00840.0130
LOD (ppm)0.00510.00500.00280.0043